Humira linked to increased cancer risk in some patients
Why Choose GB&W? results | reputation | resources
Email Us
Humira linked to increased cancer risk in some patients

Drugmaker Abbott Laboratories was recently sued by a woman who alleges that she got cancer because she used the arthritis drug Humira.

The woman was diagnosed with B-cell non-Hodgkin's follicular lymphoma after receiving bi-monthly injections of Humira for two years.

According to the complaint, Abbott was aware of clinical trial data which indicated that patients who used Humira faced a statistically significant risk of developing cancer when compared to individual who received a placebo.

Abbot's failure to warn consumers of their increased risk of cancer makes up one component of the woman's pharmaceutical product liability complaint.

"Abbott buried and information regarding malignancies in the label," the complaint alleges. "Further, what 'warning' information was mentioned severely downplayed the risk and confused the issue, consistent with its sales message, in rheumatoid arthritis data."

Courthouse News reports that the drugmaker did not add the black box warning label regarding increased cancer risks for Humira users until after the woman began using the drug, which is also known as adalimumab.

"Using adalimumab injection may decrease your ability to fight infection and increase the chance that you will develop a serious infection, including severe fungal, bacterial, and viral infection that may spread through the body," the new black box warning reads. "These infections may need to be treated in a hospital and may cause death."

Source: Courthouse News Service, "Arthritis Drug Humira Blamed for Cancer," Jack Bouboushian, July 25, 2012

No Comments

Leave a comment
Comment Information
Super Lawyers American Association For Justice Best Lawyers | Best Law Firms | U.S. News 2016 Best Lawyers | Lawyer of the Year 2010 The Inner Circle of Advocates | 7 Law Dragon Legal Leaders | Top Rated Lawyers 2015 | AV Preeminent 2015 California's Top Ranked Law Firms | AV Preeminent Martindale-Hubbell Lawyer Ratings Why Do These Logos Matter? Learn More.
Email Us For A Response

Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.